When the company formerly known as Valeant Pharmaceuticals (NYSE:BHC) came crashing down in 2015 as a result of a flawed business model, investors were left in awe as...
Sept 24 (Reuters) - Bausch Health Companies Inc BHC.TO : * BAUSCH HEALTH ANNOUNCES AVAILABILITY OF SILIQ™ (BRODALUMAB) FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE...
The Canadian stock market remains sluggish.Last week, the S&P/TSX Composite Index lost about 130 points, or 0.5%, continuing a recent multi-week downtrend....
Overnight surprises have had a significant impact on trading that could continue into today's action. President Trump surprised the world overnight by firing FBI Director Comey....
The Ides of March has arrived at last with the potential for significant market moving developments. U.S. indices and the FTSE are up 0.2% so far today. The U.S. dollar is...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||Strong Sell||Strong Sell||Sell||Strong Buy||Strong Buy|
|Summary||Strong Sell||Strong Sell||Neutral||Strong Buy||Neutral|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Upside Gap Three Methods||1M||2||Jul 18|
|Three Outside Up||1M||4||May 18|
|Bullish Engulfing||1M||5||Apr 18|
|Morning Doji Star||1M||5||Apr 18|
|Three Outside Down||1H||5||Sep 25, 2018 10:00|
|FSD Pharma B||0.720||0.790||0.660||-0.080||-10.00%||38.79M||25/09|
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.Read More
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.